163 related articles for article (PubMed ID: 21298373)
1. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1.
Tse HS; Hu HY; Sze KH
Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373
[TBL] [Abstract][Full Text] [Related]
2. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.
Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D
Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139
[TBL] [Abstract][Full Text] [Related]
3. The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1.
Andersson FI; Werrell EF; McMorran L; Crone WJ; Das C; Hsu ST; Jackson SE
J Mol Biol; 2011 Mar; 407(2):261-72. PubMed ID: 21251915
[TBL] [Abstract][Full Text] [Related]
4. Backbone assignments of the 26 kDa neuron-specific ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1).
Andersson FI; Jackson SE; Hsu ST
Biomol NMR Assign; 2010 Apr; 4(1):41-3. PubMed ID: 20012716
[TBL] [Abstract][Full Text] [Related]
5. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population.
Xue S; Jia J
Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667
[TBL] [Abstract][Full Text] [Related]
6. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.
Choi J; Levey AI; Weintraub ST; Rees HD; Gearing M; Chin LS; Li L
J Biol Chem; 2004 Mar; 279(13):13256-64. PubMed ID: 14722078
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1.
Das C; Hoang QQ; Kreinbring CA; Luchansky SJ; Meray RK; Ray SS; Lansbury PT; Ringe D; Petsko GA
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4675-80. PubMed ID: 16537382
[TBL] [Abstract][Full Text] [Related]
8. The functions of UCH-L1 and its relation to neurodegenerative diseases.
Setsuie R; Wada K
Neurochem Int; 2007; 51(2-4):105-11. PubMed ID: 17586089
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.
Mellick GD; Silburn PA
Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850
[TBL] [Abstract][Full Text] [Related]
10. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
Lee YC; Hsu SD
Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
[TBL] [Abstract][Full Text] [Related]
11. UCH-L1 S18Y variant and risk of Parkinson's disease in Asian populations: an updated meta-analysis.
Zhu R; Zhu Y; Liu X; He Z
Neurodegener Dis; 2014; 14(4):194-203. PubMed ID: 25471998
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1.
Konya C; Hatanaka Y; Fujiwara Y; Uchida K; Nagai Y; Wada K; Kabuta T
Neurochem Int; 2011 Aug; 59(2):251-8. PubMed ID: 21693148
[TBL] [Abstract][Full Text] [Related]
13. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.
Kyratzi E; Pavlaki M; Stefanis L
Hum Mol Genet; 2008 Jul; 17(14):2160-71. PubMed ID: 18411255
[TBL] [Abstract][Full Text] [Related]
14. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L
Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440
[TBL] [Abstract][Full Text] [Related]
15. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.
Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K
Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903
[TBL] [Abstract][Full Text] [Related]
16. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
[TBL] [Abstract][Full Text] [Related]
17. Characterization of multimetric variants of ubiquitin carboxyl-terminal hydrolase L1 in water by small-angle neutron scattering.
Naito S; Mochizuki H; Yasuda T; Mizuno Y; Furusaka M; Ikeda S; Adachi T; Shimizu HM; Suzuki J; Fujiwara S; Okada T; Nishikawa K; Aoki S; Wada K
Biochem Biophys Res Commun; 2006 Jan; 339(2):717-25. PubMed ID: 16316632
[TBL] [Abstract][Full Text] [Related]
18. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.
Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH
Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson's disease in the Chinese population.
Wang L; Guo JF; Nie LL; Luo L; Zuo X; Shen L; Jiang H; Yan XX; Xia K; Pan Q; Tang BS
J Clin Neurosci; 2011 Apr; 18(4):541-4. PubMed ID: 21315600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
